AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 89 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $409,000 | -9.1% | 653,993 | +22.7% | 0.00% | – |
Q3 2019 | $450,000 | +71.8% | 532,969 | +37.0% | 0.00% | – |
Q2 2019 | $262,000 | -44.6% | 388,900 | -32.6% | 0.00% | – |
Q1 2019 | $473,000 | -59.8% | 576,988 | -21.6% | 0.00% | – |
Q4 2018 | $1,178,000 | -56.6% | 736,281 | -10.3% | 0.00% | -100.0% |
Q3 2018 | $2,716,000 | +412.5% | 820,414 | +249.6% | 0.00% | – |
Q2 2018 | $530,000 | +147.7% | 234,697 | +218.4% | 0.00% | – |
Q1 2018 | $214,000 | -91.3% | 73,700 | -91.6% | 0.00% | -100.0% |
Q4 2017 | $2,449,000 | +1055.2% | 877,720 | +1413.3% | 0.00% | – |
Q3 2017 | $212,000 | +146.5% | 58,000 | +49.8% | 0.00% | – |
Q2 2017 | $86,000 | +1333.3% | 38,718 | +252.5% | 0.00% | – |
Q1 2017 | $6,000 | 0.0% | 10,983 | +2.6% | 0.00% | – |
Q4 2016 | $6,000 | -89.3% | 10,700 | -82.7% | 0.00% | – |
Q3 2016 | $56,000 | +124.0% | 61,887 | +125.4% | 0.00% | – |
Q1 2016 | $25,000 | +19.0% | 27,461 | +61.3% | 0.00% | – |
Q4 2015 | $21,000 | +75.0% | 17,028 | +73.8% | 0.00% | – |
Q3 2015 | $12,000 | -82.1% | 9,799 | -74.9% | 0.00% | – |
Q2 2015 | $67,000 | +1575.0% | 39,039 | +950.0% | 0.00% | – |
Q3 2014 | $4,000 | -88.2% | 3,718 | -72.7% | 0.00% | – |
Q2 2013 | $34,000 | – | 13,597 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |